Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 1, 2004, Pages 7-15

  Ranga, Rama S ^a   Girija, Ramankutty ^b   Nur e alam, Mohammed ^a   Sathishkumar, Sabapathy ^c   Akbarsha, Mohammed A ^b   Thirugnanam, Subbiah ^d   Rohr, Jürgen ^a   Ahmed, Mansoor M ^c   Chendil, Damodaran ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b BHARATHIDASAN UNIVERSITY   (India)

^c UNIVERSITY OF KENTUCKY   (United States)

^d NONE

Author keywords

Apoptosis induction; CAM for prostate cancer; Clonogenic inhibition; Radiosensitization; Rasagenthi lehyam; Siddha medicine

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTINEOPLASTIC AGENT; CHLOROFORM; HERBACEOUS AGENT; HEXANE; METHANOL; ORGANIC SOLVENT; RASAGENTHI LEHYAM; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IRRADIATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIZATION; STATISTICAL SIGNIFICANCE;

APOPTOSIS; CHLOROFORM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; MEDICINE, AYURVEDIC; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; QUALITY CONTROL; RADIATION-SENSITIZING AGENTS; SOLVENTS; TUMOR CELLS, CULTURED;

EID: 3042728725     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0770-9     Document Type: Article

References (57)

1. Acuna UM, Atha DE, Ma J, Nee MH, Kennelly EJ (2002) Antioxidant capacities of ten edible North American plants. Phytother Res 16:63-65
2. Aruna K, Sivaramakrishnan VM (1992) Anticarcinogenic effects of some Indian plant products. Food Chem Toxicol 30:953-956
3. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300
4. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase 111 randomised trial. Lancet 360:103-106
5. Chen X, Hasuma T, Yano Y, Yoshimata T, Morishima Y, Wang Y, Otani S (1997) Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 17:2555-2564
6. Chendil D, Oakes R, Alcock RA, Patel N, Mayhew C, Mohiuddin M, Gallicchio VS, Ahmed MM (2000) Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer 89:1893-1900
7. Chendil D, Das A, Dey S, Mohiuddin M, Ahmed MM (2002) Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Cancer Biol Ther 1:152-160
8. Chidambara Murthy KN, Singh RP, Jayaprakasha GK (2002) Antioxidant activities of grape (Vitis vinifera) pomace extracts. J Agric Food Chem 50:5909-5914
9. Dabancens A, Zipper J, Guerrero A (1994) Quinacrine and copper, compounds with anticonceptive and antineoplastic activity. Contraception 50:243-251
10. Darzynkiewicz Z, Traganos F, Wu JM, Chen S (2000) Chinese herbal mixture PC SPES in treatment of prostate cancer (review). Int J Oncol 17:729-736
11. de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schroder FH (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97:237-244
12. Devi PU, Kamath R, Rao BS (2000) Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J Exp Biol 38:432-437
13. Dorai T, Gehani N, Katz A (2000) Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4:1-6
14. Flynn DL, Rafferty MF, Boctor AM (1986) Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22:357-360
15. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT (1994) The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54:6167-6175
16. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7-33
17. Hussain SP, Rao AR (1991) Chemopreventive action of mace (Myristica fragrans, Houtt) on methylcholanthrene-induced carcinogenesis in the uterine cervix in mice. Cancer Lett 56:231-234
18. Ibrahim AS, Latif AH (2002) Adult lead poisoning from a herbal medicine. Saudi Med J 23:591-593
19. Inayat MS, Chendil D, Mohiuddin M, Elford HL, Gallicchio VS, Ahmed MM (2002) Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. Cancer Biol Ther 1:539-545
20. Jeswal P (1998) Antidotal effect of grape juice (Vitis vinifera) on ochratoxin A caused hepatorenal carcinogenesis in mice (Mus musculus). Cytobios 93:123-128
21. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO (1997) Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 277:467-471
22. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R (2002) Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology 59:272-276
23. Kao GD, Devine P (2000) Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88:615-619
24. Kasprzak KS, Diwan BA, Rice JM (1994) Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology 90:129-140
25. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 40:387-391
26. Kumar MH, Gupta YK (2002) Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism in enhancing cognition. Phytomedicine 9:302-311
27. Lee SE, Ju EM, Kim JH (2001) Free radical scavenging and antioxidant enzyme fortifying activities of extracts from Smilax china root. Exp Mol Med 33:263-268
28. Mathews V, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A (2002) Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. Am J Hematol 70:292-299
29. Mazumdar UK, Gupta M, Maiti S, Mukherjee D (1997) Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Indian J Exp Biol 35:473-477
30. Okita K, Li Q, Murakamio T, Takahashi M (1993) Antigrowth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev 2:169-175
31. Parcell S (2002) Sulfur in human nutrition and applications in medicine. Altern Med Rev 7:22-44
32. Park HJ, Jung WT, Basnet P, Kadota S, Namba T (1996) Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J Nat Prod 59:1128-1130
33. Park KK, Chun KS, Lee JM, Lee SS, Surh YJ (1998) Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129:139-144
34. Park S, Lee DK, Yang CH (1998) Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett 127:23-28
35. Paul B, Masih I, Deopujari J, Charpentier C (1999) Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol 68:71-76
36. Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP, Chapuis JC (1996) Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol 53:57-63
37. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS (2001) Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 19:1830-1838
38. Premalatha B (2000) Semecarpus anacardium Linn. nuts - a boon in alternative medicine. Indian J Exp Biol 38:1177-1182
39. Premalatha B, Sachdanandam P (2000) Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)-induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes. Pharmacol Res 42:161-166
40. Saleem A, Husheem M, Harkonen P, Pihlaja K (2002) Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol 81:327-336
41. Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR (1992) Antitumour principles from Nigella sativa seeds. Cancer Lett 63:41-46
42. See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ (2002) Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J Urol 168:429-435
43. Shaw D, Leon C, Kolev S, Murray V (1997) Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf 17:342-356
44. Shim MJ, Kim HJ, Yang SJ, Lee IS, Choi HI, Kim T (2002) Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J Biochem Mol Biol 35:377-383
45. Shukla PK, Khanna VK, Ali MM, Maurya RR, Handa SS, Srimal RC (2002) Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytother Res 16:256-260
46. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18:3595-3603
47. Smith M, Mills EJ (2001) Select complementary/alternative therapies for prostate cancer: the benefits and risks. Cancer Pract 9:253-255
48. Soleas GJ, Diamandis EP, Goldberg DM (1997) Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30:91-113
49. Srivastava KC (1988) Extract of a spice - omum (Trachyspermum ammi) - shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Prostaglandins Leukot Essent Fatty Acids 33:1-6
50. Sujatha V, Sachdanandam P (2002) Recuperative effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother Res 16 [Suppl 1]:S14-18
51. Surh YJ (2002) Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40:1091-1097
52. Surh YJ, Lee E, Lee JM (1998) Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutat Res 402:259-267
53. Vickers A, Zollman C (1999) ABC of complementary medicine: herbal medicine. BMJ 319:1050-1053
54. Waffo-Teguo P, Hawthorne ME, Cuendet M, Merillon JM, Kinghorn AD, Pezzuto JM, Mehta RG (2001) Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer 40:173-179
55. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW (2002) Attitudes and use of complementary medicine in men with prostate cancer. J Urol 168:2505-2509
56. Woynarowski JM, Napier C, Koester SK, Chen SF, Troyer D, Chapman W, MacDonald JR (1997) Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114). Biochem Pharmacol 54:1181-1193
57. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M (1994) The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the GO/G1 phase. Cancer Res 54:448-454